EP2515912A4 - PHARMACEUTICAL COMPOSITION WITH VITAMIN D ANALOGON AND COLOSTERS-TENSID MIXTURE - Google Patents
PHARMACEUTICAL COMPOSITION WITH VITAMIN D ANALOGON AND COLOSTERS-TENSID MIXTUREInfo
- Publication number
- EP2515912A4 EP2515912A4 EP09852472.1A EP09852472A EP2515912A4 EP 2515912 A4 EP2515912 A4 EP 2515912A4 EP 09852472 A EP09852472 A EP 09852472A EP 2515912 A4 EP2515912 A4 EP 2515912A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pharmaceutical composition
- vitamin
- analogue
- cosolvent
- surfactant mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DK2009/000266 WO2011076206A1 (en) | 2009-12-22 | 2009-12-22 | Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2515912A1 EP2515912A1 (en) | 2012-10-31 |
EP2515912A4 true EP2515912A4 (en) | 2013-12-25 |
Family
ID=44194970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09852472.1A Withdrawn EP2515912A4 (en) | 2009-12-22 | 2009-12-22 | PHARMACEUTICAL COMPOSITION WITH VITAMIN D ANALOGON AND COLOSTERS-TENSID MIXTURE |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2515912A4 (es) |
JP (1) | JP5548275B2 (es) |
CN (1) | CN102770143B (es) |
AU (1) | AU2009357263B2 (es) |
BR (1) | BR112012015447A2 (es) |
CA (1) | CA2785249A1 (es) |
HK (1) | HK1177695A1 (es) |
IL (1) | IL220513A (es) |
MX (1) | MX2012007227A (es) |
NZ (1) | NZ601002A (es) |
RU (1) | RU2500387C1 (es) |
WO (1) | WO2011076206A1 (es) |
ZA (1) | ZA201204619B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107643354B (zh) * | 2016-07-22 | 2022-02-01 | 重庆华邦胜凯制药有限公司 | 卡泊三醇起始原料a及相关杂质的分离与测定方法 |
CN106265485A (zh) * | 2016-08-22 | 2017-01-04 | 江苏知原药业有限公司 | 一种稳定性改善的卡泊三醇组合物 |
CN106265511A (zh) * | 2016-08-22 | 2017-01-04 | 江苏知原药业有限公司 | 一种性能优异的卡泊三醇倍他米松自微乳制剂 |
CN106344589B (zh) * | 2016-11-10 | 2019-11-26 | 江苏知原药业有限公司 | 一种稳定性改善的卡泊三醇倍他米松组合物 |
CN108904445A (zh) * | 2018-08-06 | 2018-11-30 | 江苏知原药业有限公司 | 钙泊三醇纳米悬浮液 |
WO2022040773A1 (en) * | 2020-08-26 | 2022-03-03 | Canadian Nano Pharmaceutical Technology Inc. | Nano-emulsion based compositions, methods for their preparation and their use in delivery of active ingredients |
CN115350151B (zh) * | 2022-09-29 | 2023-09-12 | 湖北欣泽霏药业有限公司 | 一种高稳定性阿法骨化醇液体口服制剂及其制备方法 |
CN116473985A (zh) * | 2023-03-29 | 2023-07-25 | 暨南大学 | 一种多烯类抗真菌药物组合物及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
US20060292080A1 (en) * | 1998-09-11 | 2006-12-28 | Connetics Australia Pty Ltd | Vitamin formulation |
US20080234239A1 (en) * | 2007-03-15 | 2008-09-25 | Derek Wheeler | Topical composition |
US20080293681A1 (en) * | 2005-11-30 | 2008-11-27 | Galderma S.A. | Sprayable pharmaceutical compositions comprising a vitamin d derivative and an oily phase |
US20090298801A1 (en) * | 2006-11-30 | 2009-12-03 | Galderma S.A. | Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763426A (en) * | 1993-01-15 | 1998-06-09 | Leo Pharmaceutical Products Ltd. | Crystalline form of a vitamin D analogue |
JP3340310B2 (ja) * | 1996-03-28 | 2002-11-05 | 株式会社資生堂 | 複合エマルジョンおよびその製造方法 |
JP4511639B2 (ja) * | 1997-12-09 | 2010-07-28 | 中外製薬株式会社 | ビタミンd3誘導体を含有するクリーム剤 |
AU743582B2 (en) * | 1997-12-09 | 2002-01-31 | Chugai Seiyaku Kabushiki Kaisha | Lotions containing vitamin D3 derivatives |
KR20010109357A (ko) * | 1999-04-23 | 2001-12-08 | 룬딩 에른스트 | 비타민 d 동족체 및 이의 약제학적 용도 |
JP2001025359A (ja) * | 1999-07-15 | 2001-01-30 | Mitsubishi-Kagaku Foods Corp | O/w/o型エマルジョン組成物およびその製造方法 |
KR20080016612A (ko) * | 2005-06-10 | 2008-02-21 | 갈데르마 소시에떼아노님 | 약물, 필름형성 실리콘 및 하나 이상의 휘발성 용매를포함하는 국소조성물을 기초로 하는 피부를 통한 약물의조절된 방출 |
CA2612408A1 (en) * | 2005-06-15 | 2006-12-28 | Apollo Pharmaceutical, Inc. | Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis |
JP4913487B2 (ja) * | 2006-07-07 | 2012-04-11 | ポーラ化成工業株式会社 | 使用感に特徴のある化粧料 |
FR2911781B1 (fr) * | 2007-01-26 | 2009-03-20 | Fabre Pierre Dermo Cosmetique | Emulsion dermatologique et procede de preparation |
EP1970049A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D and corticosteroid |
-
2009
- 2009-12-22 BR BR112012015447A patent/BR112012015447A2/pt not_active IP Right Cessation
- 2009-12-22 NZ NZ601002A patent/NZ601002A/en not_active IP Right Cessation
- 2009-12-22 WO PCT/DK2009/000266 patent/WO2011076206A1/en active Application Filing
- 2009-12-22 EP EP09852472.1A patent/EP2515912A4/en not_active Withdrawn
- 2009-12-22 CA CA2785249A patent/CA2785249A1/en not_active Abandoned
- 2009-12-22 CN CN200980163466.0A patent/CN102770143B/zh not_active Expired - Fee Related
- 2009-12-22 AU AU2009357263A patent/AU2009357263B2/en not_active Ceased
- 2009-12-22 RU RU2012130402/15A patent/RU2500387C1/ru not_active IP Right Cessation
- 2009-12-22 MX MX2012007227A patent/MX2012007227A/es active IP Right Grant
- 2009-12-22 JP JP2012545089A patent/JP5548275B2/ja not_active Expired - Fee Related
-
2012
- 2012-06-19 IL IL220513A patent/IL220513A/en not_active IP Right Cessation
- 2012-06-21 ZA ZA2012/04619A patent/ZA201204619B/en unknown
-
2013
- 2013-04-23 HK HK13104898.0A patent/HK1177695A1/xx not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
US20060292080A1 (en) * | 1998-09-11 | 2006-12-28 | Connetics Australia Pty Ltd | Vitamin formulation |
US20080293681A1 (en) * | 2005-11-30 | 2008-11-27 | Galderma S.A. | Sprayable pharmaceutical compositions comprising a vitamin d derivative and an oily phase |
US20090298801A1 (en) * | 2006-11-30 | 2009-12-03 | Galderma S.A. | Petroleum jelly-free unguent compositions comprising vitamin D compounds and optionally steroidal anti-inflammatory agents |
US20080234239A1 (en) * | 2007-03-15 | 2008-09-25 | Derek Wheeler | Topical composition |
Non-Patent Citations (1)
Title |
---|
See also references of WO2011076206A1 * |
Also Published As
Publication number | Publication date |
---|---|
CN102770143B (zh) | 2014-11-05 |
AU2009357263A1 (en) | 2012-07-19 |
MX2012007227A (es) | 2012-07-30 |
CN102770143A (zh) | 2012-11-07 |
JP2013515017A (ja) | 2013-05-02 |
RU2500387C1 (ru) | 2013-12-10 |
HK1177695A1 (en) | 2013-08-30 |
IL220513A0 (en) | 2012-08-30 |
WO2011076206A1 (en) | 2011-06-30 |
EP2515912A1 (en) | 2012-10-31 |
IL220513A (en) | 2016-05-31 |
BR112012015447A2 (pt) | 2016-03-15 |
JP5548275B2 (ja) | 2014-07-16 |
ZA201204619B (en) | 2013-09-25 |
CA2785249A1 (en) | 2011-06-30 |
AU2009357263B2 (en) | 2015-04-09 |
NZ601002A (en) | 2014-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2515912A4 (en) | PHARMACEUTICAL COMPOSITION WITH VITAMIN D ANALOGON AND COLOSTERS-TENSID MIXTURE | |
PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
MY167691A (en) | A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid | |
EA201290596A1 (ru) | Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице | |
MX363435B (es) | Formulaciones topicas que tienen biodisponibilidad aumentada. | |
CU20130069A7 (es) | Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis | |
MX2011011514A (es) | Formulaciones de canabidiol y metodos para utilizarlas. | |
WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
CL2007001972A1 (es) | Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metilpiridin-3-ilamino)-5-metilpirimidin-4-iloxi]piperidin-1-carboxilico, moduladores del metabolismo; composicion farmaceutica; y su uso para tratar trastornos metabolicos. | |
WO2012177757A3 (en) | Personal care compositions comprising shaped abrasive particles | |
MX2012003555A (es) | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. | |
BR112013018352A2 (pt) | composição de minociclina tópica e método | |
EP4306168A3 (en) | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals | |
PH12014501693A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof | |
WO2013093823A3 (en) | Topical oil composition for the treatment of fungal infections | |
IN2014DN07483A (es) | ||
MX2012007229A (es) | Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos. | |
CL2014002591A1 (es) | Composicion topica semisolida que comprende pirfenidona, dialil oxido de disulfuro modificado (odd-m), un agente gelificante y otros excipientes o aditivos; proceso para fabricarla; metodo de tratamiento; y su uso para eliminar, reducir o prevenir el acne. | |
PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
BR112014020113A8 (pt) | Composições farmacêuticas e método para diminuir a frequência de micção | |
UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
MX2010010345A (es) | Composiciones oftalmicas topicas mejoradas. | |
MY160377A (en) | Topical pharmaceutical compositions | |
MY171526A (en) | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | |
CL2015001502A1 (es) | Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120723 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA |
|
RAX | Requested extension states of the european patent have changed |
Extension state: BA Payment date: 20120723 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131122 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/192 20060101ALI20131118BHEP Ipc: A61K 9/113 20060101ALI20131118BHEP Ipc: A61K 9/00 20060101ALI20131118BHEP Ipc: A61K 31/54 20060101ALI20131118BHEP Ipc: A61K 31/405 20060101ALI20131118BHEP Ipc: A61P 17/00 20060101ALI20131118BHEP Ipc: A61K 31/59 20060101AFI20131118BHEP |
|
17Q | First examination report despatched |
Effective date: 20170104 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170315 |